Pinger Wang

Title: Pinger Wang - Innovator in Peptide Therapeutics

Introduction

Pinger Wang is a notable inventor based in North Brunswick, NJ (US). He has made significant contributions to the field of peptide therapeutics, particularly in the development of insulin and insulin-like growth factor receptor agonists and antagonists.

Latest Patents

Pinger Wang holds 1 patent for his invention titled "Insulin and IGF-1 receptor agonists and antagonists." This patent discloses peptide sequences capable of binding to insulin and/or insulin-like growth factor receptors with either agonist or antagonist activity. The invention identifies at least two different binding sites present on these receptors, which selectively bind the peptides. As agonists, these peptides may be useful for developing therapeutics to supplement or replace endogenous peptide hormones. The antagonist peptides may also be developed as therapeutics.

Career Highlights

Throughout his career, Pinger Wang has worked with prominent companies in the biotechnology sector, including Antyra Inc. and Novo Nordisk A/S. His work has focused on advancing the understanding and application of peptide-based therapies.

Collaborations

Pinger has collaborated with talented individuals in his field, including Renuka Pillutla and Olga Dedova, who have contributed to his research and development efforts.

Conclusion

Pinger Wang's innovative work in peptide therapeutics highlights his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of conditions related to insulin and growth factors.